Amoy Diagnostics Co Ltd
SZSE:300685

Watchlist Manager
Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd
SZSE:300685
Watchlist
Price: 23.51 CNY -1.84% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Amoy Diagnostics Co Ltd?
Write Note

Amoy Diagnostics Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amoy Diagnostics Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Amoy Diagnostics Co Ltd
SZSE:300685
Total Current Assets
ÂĄ1.7B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Current Assets
ÂĄ29.8B
CAGR 3-Years
-3%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Current Assets
ÂĄ11B
CAGR 3-Years
-6%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Current Assets
ÂĄ10.3B
CAGR 3-Years
73%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Current Assets
ÂĄ46.8B
CAGR 3-Years
29%
CAGR 5-Years
41%
CAGR 10-Years
40%
Imeik Technology Development Co Ltd
SZSE:300896
Total Current Assets
ÂĄ4.3B
CAGR 3-Years
-1%
CAGR 5-Years
70%
CAGR 10-Years
N/A
No Stocks Found

Amoy Diagnostics Co Ltd
Glance View

Market Cap
9.4B CNY
Industry
Biotechnology

Amoy Diagnostics Co., Ltd., nestled in the bustling city of Xiamen, China, has carved out a niche in the world of molecular diagnostics. Founded in 2008, the company has quickly become a pioneer in precision medicine, focusing on the development and commercialization of technologies for the detection of genetic mutations. At the heart of its operation lies its proprietary ADx-ARMS technology, an innovative method allowing for the precise and sensitive detection of mutations in tumor tissues and blood, facilitating oncology diagnostics. This technology not only empowers oncologists with critical insights for tailored cancer treatments but underscores Amoy Diagnostics' commitment to transforming patient care through cutting-edge genetic testing. The commercial prowess of Amoy Diagnostics is, however, much more than its technological innovations. The company thrives on a robust business model that hinges on a symbiotic relationship with the pharmaceutical industry and healthcare providers. By offering diagnostic services and research kits, Amoy Diagnostics provides crucial support in the development of targeted therapies, enabling pharmaceutical companies to test and bring to market personalized medicine solutions. Their revenue stream is bolstered by strategic partnerships and licensing agreements, which allow them to expand their portfolio and market reach both domestically and internationally. This dynamic approach not only ensures a wide adoption of their diagnostic solutions but also firmly positions Amoy Diagnostics as a key player in the rapidly growing field of precision oncology.

Intrinsic Value
28.03 CNY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Amoy Diagnostics Co Ltd's Total Current Assets?
Total Current Assets
1.7B CNY

Based on the financial report for Sep 30, 2024, Amoy Diagnostics Co Ltd's Total Current Assets amounts to 1.7B CNY.

What is Amoy Diagnostics Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
17%

Over the last year, the Total Current Assets growth was 19%. The average annual Total Current Assets growth rates for Amoy Diagnostics Co Ltd have been 15% over the past three years , 17% over the past five years .

Back to Top